Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · CMS publication 2026-06-30 View official record

Covered recipient · General Payments record

NJIRA L LUGOGO

Allopathic & Osteopathic Physicians Internal Medicine Pulmonary Disease

NPI
1649219734
CMS profile
210573
Location
ANN ARBOR, MI

A name match is not confirmation of identity. CMS publishes records for different people under similar names; the NPI, specialty, and location shown on this page are the CMS-published fields that distinguish them.

Saved items

Saved only in this browser. No account or alerts.

Filter and download payment records

General Payments · PY2023 · Entire year

$173,062.01

100 records · 0 disputed

Summary and payment records

  • CMS publication 2026-06-30
Read the payment records

Other CMS categories — not shown on this page

Research Payments

CMS also publishes Research Payments as a separate dataset. This site does not currently mirror it, and no research figure is shown on this page. This provider appears in that dataset.

“If you are a physician who served as a principal investigator on a research study, you may see the payments associated with that research study listed under your name. This does not necessarily mean the payments are attributed to you. The dollar amount of the record corresponds to the total payment; the amounts are not attributed to each individual on the record.”

— Centers for Medicare & Medicaid Services, Open Payments Frequently Asked Questions, FAQ #12224

These records are published by CMS and can be viewed on this provider’s official CMS record. View this provider on CMS Open Payments ↗

“Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.”

— Centers for Medicare & Medicaid Services, Open Payments

A reported payment reflects a financial relationship a company disclosed. It does not indicate wrongdoing or a conflict of interest, and it says nothing about the quality of a provider's care.

These records are submitted to CMS and attested to by the reporting companies. CMS publishes them as reported; this site mirrors them without independent verification.

A payment attributed to a provider may have been made to a third party — a hospital, practice, or research institution — rather than paid to the provider personally.

How these totals are calculated
  • This total is the sum of the individual General Payments record amounts CMS published for the labeled program year(s); each record amount is used unmodified. The total itself is computed by this site. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Methodology & Data — sourcing, labeling, and limitations.

Provider summaries generated . CMS updates this data on an annual cycle, and corrections or successful disputes made at CMS may not yet appear here. The official CMS record is authoritative for the current state. View the official CMS record ↗

By nature of payment

PY2023 · entire year · sorted by reported total

By paying entity

PY2023 · entire year · sorted by reported total

Paying entityAmountRecords
GlaxoSmithKline, LLC. $85,514.61 39
Teva Pharmaceuticals USA, Inc. $33,076.60 16
AstraZeneca Pharmaceuticals LP $18,442.95 19
GENZYME CORPORATION $14,450.00 6
Regeneron Healthcare Solutions, Inc. $9,252.00 5
AstraZeneca AB $5,370.00 5
Regeneron Pharmaceuticals, Inc. $4,845.00 5
Amgen Inc. $1,971.00 1
AstraZeneca UK Limited $111.49 3
Genentech USA, Inc. $28.36 1

Payment records · PY2023

Ordering applied by this site (date, newest first, then paying entity) · record values are shown as CMS published them

General Payments · PY2023 · Physicians and non-physician practitioners · CMS publication 2026-06-30

100 matching records · $173,062.01 reported total · 0 disputed

Nature of payment: All payment types

Records imported here (UTC).

Link to these filtered records · CMS source dataset ↗

Download all 100 matching records (CSV)

CSV includes CMS record IDs, source and publication dates, the data edition, and a link to these filters. Formula-like text cells are prefixed with an apostrophe for spreadsheet safety.

Showing records 1–50 of 100.

Paying entityAmountDate Nature of paymentDispute statusPublication flagsPublished Record IDSource
Teva Pharmaceuticals USA, Inc. $2,620.0012/22/2023 Consulting Fee No dispute reported Delay: No
Change: UNCHANGED
06/30/20261056825709 CMS
Teva Pharmaceuticals USA, Inc. $246.0512/14/2023 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/20261056825891 CMS
AstraZeneca Pharmaceuticals LP $805.5012/11/2023 Consulting Fee No dispute reported Delay: No
Change: UNCHANGED
06/30/20261011651883 CMS
GlaxoSmithKline, LLC. $2,275.0011/16/2023 Consulting Fee No dispute reported Delay: No
Change: UNCHANGED
06/30/20261003107999 CMS
Teva Pharmaceuticals USA, Inc. $93.4311/10/2023 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/20261056825895 CMS
GlaxoSmithKline, LLC. $4,550.0011/06/2023 Consulting Fee No dispute reported Delay: No
Change: UNCHANGED
06/30/20261003084385 CMS
GlaxoSmithKline, LLC. $800.7811/06/2023 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/20261003091691 CMS
AstraZeneca Pharmaceuticals LP $9,263.2511/03/2023 Consulting Fee No dispute reported Delay: No
Change: UNCHANGED
06/30/20261011260705 CMS
GlaxoSmithKline, LLC. $32.7510/31/2023 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/20261061460996 CMS
GlaxoSmithKline, LLC. $28.2410/31/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/20261061463578 CMS
Amgen Inc. $1,971.0010/27/2023 Consulting Fee No dispute reported Delay: No
Change: UNCHANGED
06/30/20261020046361 CMS
Teva Pharmaceuticals USA, Inc. $615.0010/27/2023 Consulting Fee No dispute reported Delay: No
Change: UNCHANGED
06/30/20261056825677 CMS
Teva Pharmaceuticals USA, Inc. $982.5010/13/2023 Consulting Fee No dispute reported Delay: No
Change: UNCHANGED
06/30/20261056825719 CMS
Teva Pharmaceuticals USA, Inc. $6,877.5010/13/2023 Consulting Fee No dispute reported Delay: No
Change: UNCHANGED
06/30/20261056825721 CMS
Teva Pharmaceuticals USA, Inc. $82.8510/13/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/20261056825845 CMS
Teva Pharmaceuticals USA, Inc. $431.9410/13/2023 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/20261056825847 CMS
AstraZeneca Pharmaceuticals LP $19.6210/10/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/20261014189995 CMS
GlaxoSmithKline, LLC. $18.9310/10/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/20261003084267 CMS
GlaxoSmithKline, LLC. $21.8010/09/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/20261003107969 CMS
Teva Pharmaceuticals USA, Inc. $1,410.7910/08/2023 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/20261056825715 CMS
Teva Pharmaceuticals USA, Inc. $8,764.4510/08/2023 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/20261056825841 CMS
AstraZeneca Pharmaceuticals LP $1,745.2510/04/2023 Consulting Fee No dispute reported Delay: No
Change: UNCHANGED
06/30/20261016259127 CMS
Teva Pharmaceuticals USA, Inc. $9,532.5010/04/2023 Consulting Fee No dispute reported Delay: No
Change: UNCHANGED
06/30/20261056825675 CMS
Teva Pharmaceuticals USA, Inc. $245.2510/04/2023 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/20261056825885 CMS
GlaxoSmithKline, LLC. $6,337.5009/14/2023 Consulting Fee No dispute reported Delay: No
Change: UNCHANGED
06/30/20261061463840 CMS
AstraZeneca UK Limited $33.9609/11/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/20261017051321 CMS
Teva Pharmaceuticals USA, Inc. $248.3808/25/2023 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/20261056825839 CMS
GlaxoSmithKline, LLC. $34.7808/19/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/20261003082255 CMS
GlaxoSmithKline, LLC. $58.3208/19/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/20261003084283 CMS
GlaxoSmithKline, LLC. $69.9908/19/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/20261003084431 CMS
GlaxoSmithKline, LLC. $78.1108/19/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/20261003110127 CMS
GlaxoSmithKline, LLC. $44.0608/19/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/20261003110157 CMS
GlaxoSmithKline, LLC. $101.5608/18/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/20261003086123 CMS
GlaxoSmithKline, LLC. $281.3708/18/2023 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/20261003090029 CMS
GlaxoSmithKline, LLC. $1,300.0008/11/2023 Consulting Fee No dispute reported Delay: No
Change: UNCHANGED
06/30/20261003108049 CMS
Teva Pharmaceuticals USA, Inc. $327.0008/10/2023 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/20261056825889 CMS
GlaxoSmithKline, LLC. $9,750.0008/08/2023 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/20261003129935 CMS
GlaxoSmithKline, LLC. $430.6207/27/2023 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/20261003087945 CMS
GlaxoSmithKline, LLC. $1,300.0007/25/2023 Consulting Fee No dispute reported Delay: No
Change: UNCHANGED
06/30/20261003082243 CMS
Teva Pharmaceuticals USA, Inc. $163.5007/25/2023 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/20261056825879 CMS
GENZYME CORPORATION $250.0007/23/2023 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/20261049944197 CMS
AstraZeneca Pharmaceuticals LP $78.7907/22/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/20261011997433 CMS
AstraZeneca Pharmaceuticals LP $49.9907/22/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/20261014158473 CMS
AstraZeneca Pharmaceuticals LP $134.9907/21/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/20261011314143 CMS
AstraZeneca Pharmaceuticals LP $259.5007/21/2023 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/20261011631957 CMS
AstraZeneca Pharmaceuticals LP $59.9907/21/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/20261011761449 CMS
AstraZeneca Pharmaceuticals LP $48.1507/21/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/20261014728917 CMS
AstraZeneca Pharmaceuticals LP $49.9907/21/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/20261015601921 CMS
AstraZeneca Pharmaceuticals LP $259.5007/20/2023 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/20261011886105 CMS
AstraZeneca Pharmaceuticals LP $209.7107/20/2023 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/20261015846681 CMS

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2019 $88,484.69 119
PY2020 $69,221.75 20
PY2021 $42,791.40 17
PY2022 $88,290.39 67
PY2023 $173,062.01 100
PY2024 $135,779.52 105
PY2025 $143,281.81 107

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-06-30
Program years on this page
2019, 2020, 2021, 2022, 2023, 2024, 2025
Source files and profile matching
Generated from
OP_DTL_GNRL_PGYR2025_P06302026_06032026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.

Cite this record.

Plain
NJIRA L LUGOGO, NPI 1649219734. IndustryPayments, data edition 2026-07-26T04:22:22Z. https://industrypayments.org/provider/npi-1649219734.
APA 7
IndustryPayments. (2026). NJIRA L LUGOGO, NPI 1649219734 (Data edition 2026-07-26T04:22:22Z) [Data set]. https://industrypayments.org/provider/npi-1649219734
Bluebook
NJIRA L LUGOGO, NPI 1649219734, IndustryPayments (data edition 2026-07-26T04:22:22Z), https://industrypayments.org/provider/npi-1649219734.

Source: Centers for Medicare & Medicaid Services, Open Payments.